Telos Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Sell
14,035
-325
-2% -$38K 0.16% 106
2026
Q1
$1.73M Sell
14,360
-816
-5% -$94.2K 0.17% 98
2025
Q4
$1.6M Sell
15,176
-507
-3% -$47.6K 0.15% 105
2025
Q3
$1.32M Sell
15,683
-165
-1% -$13.6K 0.13% 111
2025
Q2
$1.25M Buy
15,848
+1,071
+7% +$85.1K 0.13% 113
2025
Q1
$1.33M Sell
14,777
-72
-0.5% -$6.72K 0.14% 105
2024
Q4
$1.48M Sell
14,849
-155
-1% -$16K 0.16% 102
2024
Q3
$1.7M Sell
15,004
-317
-2% -$37.7K 0.18% 98
2024
Q2
$1.9M Buy
15,321
+515
+3% +$66.3K 0.21% 91
2024
Q1
$1.95M Sell
14,806
-865
-6% -$107K 0.22% 94
2023
Q4
$1.71M Buy
15,671
+1,897
+14% +$197K 0.21% 93
2023
Q3
$1.42M Buy
13,774
+985
+8% +$106K 0.2% 92
2023
Q2
$1.48M Buy
12,789
+2,662
+26% +$302K 0.2% 93
2023
Q1
$1.08M Sell
10,127
-29
-0.3% -$3.13K 0.15% 105
2022
Q4
$1.13M Buy
10,156
+317
+3% +$32.4K 0.16% 102
2022
Q3
$847K Sell
9,839
-46
-0.5% -$4.11K 0.14% 107
2022
Q2
$901K Sell
9,885
-1,578
-14% -$140K 0.14% 107
2022
Q1
$941K Sell
11,463
-878
-7% -$69.2K 0.12% 112
2021
Q4
$946K Sell
12,341
-26,275
-68% -$2.09M 0.12% 110
2021
Q3
$2.9M Sell
38,616
-10,301
-21% -$783K 0.4% 81
2021
Q2
$3.8M Sell
48,917
-3,863
-7% -$287K 0.5% 69
2021
Q1
$3.88M Sell
52,780
-956
-2% -$70.5K 0.56% 68
2020
Q4
$4.19M Sell
53,736
-3,285
-6% -$251K 0.64% 57
2020
Q3
$4.51M Sell
57,021
-37
-0.1% -$2.9K 0.79% 42
2020
Q2
$4.21M Buy
57,058
+5,476
+11% +$412K 0.81% 39
2020
Q1
$3.79M Buy
51,582
+24,119
+88% +$1.9M 0.94% 33
2019
Q4
$2.38M Buy
27,463
+6,110
+29% +$502K 0.54% 69
2019
Q3
$1.72M Buy
21,353
+3,018
+16% +$242K 0.47% 77
2019
Q2
$1.47M Buy
18,335
+2,038
+13% +$156K 0.43% 78
2019
Q1
$1.29M Buy
16,297
+22
+0.1% +$1.65K 0.4% 79
2018
Q4
$1.19M Buy
16,275
+249
+2% +$17.6K 0.44% 78
2018
Q3
$1.08M Sell
16,026
-335
-2% -$21.3K 0.35% 84
2018
Q2
$948K Sell
16,361
-2,618
-14% -$148K 0.33% 84
2018
Q1
$987K Sell
18,979
-1,234
-6% -$66.6K 0.35% 83
2017
Q4
$1.08M Buy
20,213
+100
+0.5% +$5.54K 0.38% 80
2017
Q3
$1.23M Buy
20,113
+377
+2% +$22.9K 0.47% 79
2017
Q2
$1.21M Buy
19,736
+494
+3% +$30.1K 0.48% 76
2017
Q1
$1.17M Sell
19,242
-678
-3% -$41.1K 0.49% 75
2016
Q4
$1.12M Buy
19,920
+2,744
+16% +$161K 0.5% 75
2016
Q3
$1.02M Buy
17,176
+1,331
+8% +$77.8K 0.48% 73
2016
Q2
$871K Buy
15,845
+814
+5% +$43.3K 0.43% 80
2016
Q1
$759K Sell
15,031
-729
-5% -$35.7K 0.4% 80
2015
Q4
$794K Sell
15,760
-37
-0.2% -$1.86K 0.43% 81
2015
Q3
$744K Sell
15,797
-276
-2% -$14.7K 0.45% 81
2015
Q2
$873K Buy
16,073
+5,176
+47% +$290K 0.48% 79
2015
Q1
$598K Buy
10,897
+812
+8% +$46K 0.35% 90
2014
Q4
$547K Buy
10,085
+749
+8% +$41.7K 0.33% 93
2014
Q3
$528K Sell
9,336
-246
-3% -$13.8K 0.33% 98
2014
Q2
$529K Buy
9,582
+922
+11% +$50.3K 0.33% 98
2014
Q1
$469K Buy
8,660
+610
+8% +$31.6K 0.33% 94
2013
Q4
$384K Buy
8,050
+603
+8% +$27.6K 0.28% 100
2013
Q3
$338K Sell
7,447
-749
-9% -$34.2K 0.27% 104
2013
Q2
$363K Buy
+8,196
New +$366K 0.32% 98

Other funds holding MRK

Telos Capital Management's MRK Position: Q2 2026 in Review

Telos Capital Management reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $38K and leaving 14,035 shares worth $1.8M. The position accounts for 0.16% of the portfolio, ranked #106.

Telos Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.51M in Q3 2020. 1,362 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Telos Capital Management held 14,035 shares of Merck worth $1.8M as of Q2 2026.
  • Telos Capital Management sold 325 Merck shares in Q2 2026, an estimated $38K.
  • Merck made up 0.16% of Telos Capital Management's portfolio in Q2 2026, its #106 holding.
  • Telos Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Telos Capital Management's Merck position peaked at $4.51M in Q3 2020.
  • 1,362 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.